Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
51094-1-AP targets MEK6 in WB, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | mitogen-activated protein kinase kinase 6 |
| Calculated Molecular Weight | 334 aa, 37 kDa |
| Observed Molecular Weight | 36 kDa |
| GenBank Accession Number | BC012009 |
| Gene Symbol | MEK6 |
| Gene ID (NCBI) | 5608 |
| RRID | AB_2881246 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P52564 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MAPKK6 (Dual specificity mitogen activated protein kinase kinase 6), also known as MAP2K6 / MEK6 / MKK6, is a member of MAPKK protein kinase family. MKK6 plays an important role in intracellular signaling pathways leading toward activation of the p38 MAP kinase. MEK6 phosphorylates and activates p38 MAP kinase in response to inflammatory cytokines or environmental stress. MEK6 plays a complex role in cancer, with some evidence showing it can promote tumor growth. Overexpression of MEK6 has been linked to decreased survival in lung adenocarcinoma, breast cancer, and melanoma.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for MEK6 antibody 51094-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
MEK6 Polyclonal antibody (Cat# 51094-1-AP) has 1 total citation.
Journal: Neoplasma
Research field: Oncology — the study investigated an antitumor peptide's effects on glioma cells, showing inhibition of proliferation and migration and promotion of apoptosis through regulation of the MKK6/p38 signaling pathway.
Application/Species: The antibody was used in Western blot analysis of human samples (KD/KO validated, reactive in human).
The MEK6/MAP2K6 antibody targets the p38 MAP kinase pathway relevant to cancer biology, including lung adenocarcinoma, breast cancer, and melanoma research.
| Species | Application | Title |
|---|---|---|
Neoplasma A novel antitumor peptide inhibits proliferation and migration and promotes apoptosis in glioma cells by regulating the MKK6/p38 signaling pathway. |



